logo
Share SHARE
FONT-SIZE Plus   Neg

Willis Group Appoints Gioia Ghezzi As COO

Insurance broker Willis Group Holdings plc (WSH) said Monday that it has appointed Gioia Ghezzi as Chief Operating Officer, effective immediately.

In her new role, Ghezzi will oversee a number of corporate functions and manage a global structure designed to drive revenue growth and increase operational efficiencies across the Group. She succeeds Tim Wright, now the CEO of Willis International, who served in the Chief Operating Officer role for four years.

Ghezzi joins Willis Group most recently from McKinsey & Co, where she spent 11 years as partner and leader of the Insurance and Health practices providing advice on company strategy, operations, and performance transformation to a large number of global clients.

Willis Group also said that Adam Rosman will be appointed Group General Counsel, overseeing the Group's worldwide legal, compliance, risk, corporate secretary, and audit functions.

Rosman has served as Group Deputy General Counsel and General Counsel for Willis North America for the past three years. He succeeds Adam Ciongoli, who is leaving the company in May to serve as General Counsel of Lincoln Financial Group.

Ghezzi will be based at the Willis building in London while Rosman will remain in New York.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fast food giant McDonald's on Wednesday announced its global growth plan, targeting sales growth of 3-5% beginning in 2019. The company also highlighted its vision for new restaurants relying on technology such as self-ordering kiosks, curbside pick ups and partnerships with delivery services. At... Canadian drug-maker Valeant Pharmaceuticals International, Inc. on Tuesday reported a loss for the fourth quarter that widened from last year on a double-digit decline in revenues. However, both revenue and adjusted earnings beat analysts' estimates. Valeant also said it plans to relaunch its sexual dysfunction drug Addyi in the U.S. Electronics retailer Best Buy Co., Inc. Wednesday issued guidance for first-quarter adjusted earnings and revenues, below market estimates. Comparable sales are expected to be weak. For fiscal 2018, the company projects higher revenues and operating income. In its fourth quarter, the company posted higher profit, above market view, while revenues missed estimates with lower comparable sales.
comments powered by Disqus
Follow RTT